Alembic Limited
NSE: ALEMBICLTD · Residential, Commercial Projects · sector
Key numbers
Last 12 months to Jun 2026, Consolidated. "Sector median" = middle value of 141 companies in Residential, Commercial Projects (P/E median leaves out loss-making companies). Tap ? for what a number means.
Things to know
- Cash ₹100 cr vs borrowings ₹11 cr (FY26): cash is higher (net cash).
- Operating profit covered interest 64.9x in the last 12 months.
- No promoter shares are pledged.
- Promoter holding rose by 0.53 percentage points in a year, to 71.41% (2026-09-30).
- Operating cash flow was below net profit in 5 of the last 5 years (FY26, FY25, FY24, FY23, FY22).
- Net loss in 1 of the last 8 quarters.
- Revenue was higher than a year earlier in 2 of the last 4 quarters.
- Other income was 34% of net profit in the last 12 months.
- Dividend paid in 5 of the last 5 financial years.
- Price ₹84.69 on 2026-10-26: -28.1% from the 52-week high, +20.2% from the 52-week low.
Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.
Charts
Quarterly results
| ₹ cr | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 53 | 58 | 60 | 50 | 56 | 74 | 60 | 49 |
| EBITDA | 20 | 26 | 27 | 20 | 23 | 27 | 20 | 15 |
| OPM % | 37.0% | 45.6% | 45.3% | 39.4% | 41.6% | 36.9% | 33.7% | 31.7% |
| Other income | 66 | 4 | 3 | 4 | 65 | 2 | 2 | 6 |
| Net profit | 121 | 65 | 68 | 62 | 128 | 60 | -34 | 65 |
| EPS (₹) | 4.71 | 2.55 | 2.67 | 2.40 | 5.00 | 2.34 | 2.61 | 2.53 |
| Revenue YoY | +5.6% | +28.3% | -0.4% | -2.0% | ||||
| Profit YoY | +6.2% | -8.0% | -149.5% | +5.3% |
Consolidated figures where filed. Latest quarter Jun 2026.
Profit & loss (yearly)
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 | TTM |
|---|---|---|---|---|---|---|
| Revenue | 78 | 127 | 157 | 222 | 240 | 239 |
| EBITDA | 14 | 30 | 57 | 94 | 90 | 86 |
| Net profit | 222 | 191 | 269 | 311 | 230 | 220 |
| EPS (₹) | 8.65 | 7.43 | 10.46 | 12.10 | 12.36 | 12.48 |
| Revenue growth | +62.7% | +23.8% | +40.9% | +8.2% | +8.2% | |
| Profit growth | -14.1% | +40.9% | +15.7% | -26.0% | -30.6% | |
| Dividend / share (₹) | 0.20 | 1.80 | 2.20 | 2.40 | 2.40 |
| Compounded growth | 3 years | 5 years | Last 12 months |
|---|---|---|---|
| Sales | +23.6% | +26.7% | +8.2% |
| Net profit | +6.4% | -7.7% | -30.6% |
| EPS | +18.5% | -1.5% | – |
| Share price | – | -15.0% (2y) | -10.3% |
Balance sheet
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Shareholders' equity | – | 2,078 | 2,186 | 2,339 | 2,445 |
| Borrowings | – | 0 | 9 | 14 | 11 |
| Cash & equivalents | – | 47 | 14 | 59 | 100 |
| Total assets | – | 2,205 | 2,329 | 2,503 | 2,590 |
| Fixed assets | – | 132 | 131 | 135 | 170 |
| Capital work in progress | – | 0 | 1 | 0 | 2 |
| Investments | – | 374 | 313 | 277 | 173 |
| Receivables | – | 23 | 20 | 30 | 32 |
| Inventory | – | 89 | 93 | 99 | 52 |
| Payables | – | 17 | 31 | 28 | 24 |
Year-end figures from the March annual filing.
Cash flow
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash from operations | -18 | 39 | 23 | 86 | 120 |
| Cash from investing | 19 | 7 | 26 | -27 | -54 |
| Cash from financing | -6 | -46 | -48 | -58 | -68 |
| Capex | 1 | 0 | 1 | 7 | 38 |
| Free cash flow | -19 | 39 | 21 | 80 | 82 |
Free cash flow = cash from operations − capex.
Ratios by year
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| ROE % | – | 9.2% | 12.3% | 13.3% | 9.4% |
| ROCE % | – | 4.2% | 4.7% | 6.7% | 6.2% |
| Debtor days | – | 67 | 46 | 49 | 49 |
| Inventory days | – | 5,120 | 3,697 | 3,979 | 1,161 |
| Payable days | – | 1,004 | 1,238 | 1,132 | 530 |
| Cash conversion cycle (days) | – | 4,183 | 2,505 | 2,896 | 680 |
| Working capital days | – | 253 | 109 | 155 | 146 |
Shareholding
| Holder | % (2026-09-30) |
|---|---|
| Promoters | 71.41% |
| FIIs | 1.34% |
| DIIs | 0.05% |
| of which Mutual funds | 0.00% |
| Public (non-institutions) | 27.20% |
| Quarter | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters % | 70.88% | 70.88% | 70.88% | 70.88% | 70.88% | 70.88% | 70.88% | 71.41% |
| Promoter group | % |
|---|---|
| Nirayu Private Limited | 63.58% |
| Chirayu Ramanbhai Amin | 3.24% |
| Malika Chirayu Amin | 2.99% |
| Pranav Chirayu Amin | 0.75% |
| Shaunak Chirayu Amin | 0.75% |
| Inaaya Shaunak Amin | 0.02% |
| Naintara Shaunak Amin | 0.02% |
| Ranvir Pranav Amin | 0.02% |
| Samira Pranav Amin | 0.02% |
| Barkha Pranav Amin | 0.00% |
| Krupa Shaunak Amin | 0.00% |
| Chirayu Ramanbhai Amin HUF | 0.00% |
| Paushak Limited | 0.00% |
| Shreno Publications Limited | 0.00% |
| Alembic Pharmaceuticals Limited | 0.00% |
| Public holders above 1% | % |
|---|---|
| Investors Education and Protection Fund | 1.29% |
1,00,706 shareholders. Pledged: 0.00% of promoter shares.
Peers in Residential, Commercial Projects
| Company | Market cap | P/E | P/B | ROE | ROCE | OPM | Sales 3y | Div yield |
|---|---|---|---|---|---|---|---|---|
| DLF | ₹1,63,939 cr | 35.9x | 3.6x | 10.3% | 6.3% | 14.8% | +12.9% | 0.90% |
| LODHA | ₹97,912 cr | 23.7x | 4.2x | 19.0% | 17.9% | 32.2% | +20.8% | 0.43% |
| PHOENIXLTD | ₹67,737 cr | 52.9x | 6.2x | 11.9% | 15.4% | 59.1% | +18.8% | 0.13% |
| PRESTIGE | ₹60,152 cr | 52.8x | 3.7x | 7.2% | 10.5% | 28.1% | +15.1% | 0.12% |
| OBEROIRLTY | ₹57,522 cr | 21.9x | 3.0x | 14.7% | 16.9% | 57.1% | +12.8% | 0.51% |
| GODREJPROP | ₹45,942 cr | 28.7x | 2.4x | 8.8% | 6.9% | -7.7% | +31.6% | – |
| BRIGADE | ₹17,781 cr | 25.6x | 2.6x | 11.2% | 10.9% | 27.0% | +18.3% | 0.35% |
| ANANTRAJ | ₹16,514 cr | 27.8x | 2.9x | 11.6% | 11.1% | 27.0% | +37.9% | 0.15% |
| SOBHA | ₹12,247 cr | 64.1x | 2.6x | 4.1% | 6.5% | 6.5% | +16.2% | 0.26% |
| ALEMBICLTD | ₹2,175 cr | 6.8x | 0.9x | 9.2% | 6.0% | 36.1% | +23.6% | 2.82% |
Business segments (FY26)
| Segment | Revenue | Share | EBIT | Margin |
|---|---|---|---|---|
| Real Estate Business | ₹193 cr | 80.6% | ₹81 cr | 42.0% |
| Active Pharmaceutical Ingredients Business | ₹47 cr | 19.4% | ₹6 cr | 12.1% |
Dividends & corporate actions
| Ex-date | Action | Detail |
|---|---|---|
| 2026-08-04 | Dividend | Dividend - Rs 2.40 Per Share |
| 2025-08-05 | Dividend | Dividend - Rs 2.40 Per Share |
| 2024-08-05 | Dividend | Dividend - Rs 2.4 Per Share |
| 2023-08-03 | Dividend | Dividend - Rs 2.20 Per Share |
| 2022-09-12 | Dividend | Dividend - Rs 1.80 Per Share |
| 2021-07-29 | Dividend | Annual General Meeting/Dividend - Rs 0.20 Per Share |
| 2020-07-29 | Dividend | Annual General Meeting/Dividend - Rs 0.60 Per Share |
| 2019-09-18 | Dividend | Annual General Meeting/Dividend - Rs 0.20 Per Share |
| 2019-08-26 | Restructuring | Demerger |
| 2018-07-27 | Dividend | Annual General Meeting/Dividend- Re 0.20 Per Share |
| 2018-03-22 | Buyback | Buyback |
| 2017-07-19 | Dividend | Annual General Meeting/Dividend - Re 0.20 Per Share |
| 2016-08-01 | Dividend | Annual General Meeting/ Dividend - Re 0.15/- Per Share |
| 2015-08-03 | Dividend | Annual General Meeting/ Dividend - Re 0.15/- Per Share |
| 2014-08-04 | Dividend | Annual General Meeting/Dividend Re 0.15/- Per Share |
| 2013-09-27 | Bonus | Bonus 1:1 |
| 2013-08-26 | Dividend | Annual General Meeting And Dividend Re.0.20 Per Share (Bc Dates Revised) |
| 2012-08-02 | Other | Annual General Meeting |
| 2011-08-16 | Other | Annual General Meeting (Bc Dates Revised) |
| 2011-04-11 | Restructuring | Scheme Of Arrangement |
Documents
- Annual report FY26
- Annual report FY25
- Annual report FY24
- Annual report FY23
- Annual report FY22
- Announcements NSE filings
- BRSR FY26
- Latest results (data file) XBRL
- Announcements BSE filings
Links go to the original files on the exchange website.
About the company
- Real Estate: Residential & Commercial Real Estate & Leasing
- API Manufacturing: Manufacturing of pharmaceutical intermediates and generic APIs (bulk drugs)
| Sector | Consumer Discretionary |
| Industry | Residential, Commercial Projects |
| Sub-industry | Residential, Commercial Projects |
| Symbol | ALEMBICLTD |
| BSE code | 506235 |
| ISIN | INE426A01027 |
| Face value | ₹2.0 |
| Incorporated | 1907-07-30 |
| Website | www.alembiclimited.com |
| Plants (India / abroad) | 3 / 0 |
From the company's filings (BRSR FY26).
Data built 2026-10-23 from NSE company filings (XBRL: Integrated Filing - Financials + financial results), NSE shareholding & pledge data; price = NSE close 2026-10-26.